Spironolactone pour Perte Capillaire Féminine

Q: Does Spironolactone help with Perte Capillaire Féminine?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that Spironolactone may support Perte Capillaire Féminine management. Our evidence grade is A (Strong Evidence).

Q: How much Spironolactone should I take for Perte Capillaire Féminine?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Spironolactone?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Spironolactone and Perte Capillaire Féminine?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

Basé sur 19 études (2 meta-analyses, 4 RCTs) avec 5,743 participants au total. 16/19 études montrent des effets positifs.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dspironolactone\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

En conclusion

Spironolactone is strongly supported by research as an effective option that may help women with female pattern hair loss, with both oral and topical formulations showing benefits in clinical trials.

84% of studies show positive effects, including 4 RCTs focused on women
Both oral and topical formulations have demonstrated benefits
A dedicated meta-analysis confirms efficacy and safety in female pattern hair loss
Combination with minoxidil may offer enhanced results

Key Study Findings

Review

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.

Dose: None vs: None Outcome: None Effet: None None

Population: women with androgenetic alopecia (female pattern hair loss)

Randomized Controlled Trial n=204 24 weeks Double-blind

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial.

Dose: Bicalutamide 50 mg/day; spironolactone 100 mg/day vs: Spironolactone 100 mg/day Outcome: Hair density and shaft diameter change at 24 … Effet: Frontal: +5.05 vs +3.13 hairs/cm2 (diff 1.92) P < 0.001 (frontal); P = 0.028

Population: Women 18-50 with Sinclair Grade II-V FPHL (India)

randomized controlled trial n=80 24 weeks Single-blind

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment …

Dose: Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily vs: Placebo Effet: Both groups showed statistically significant improvement. Group A: 10 mild, 16 moderate, 2 excellent None

RCT n=48 24 weeks Double-blind

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a …

Dose: Spironolactone 100 mg once daily vs: Placebo Effet: Terminal hair counts: 9.48 vs 5.32 hairs/cm2; hair diameter: 4.23 vs 2.96 μm; moderate-to-marked imp p=0.063 (terminal hair counts)

Randomized Controlled Trial n=240 520 weeks Open-label

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of …

Dose: None vs: Laparoscopic Roux-en-Y gastric bypass (LRYGB) Outcome: Nutritional deficiency prevalence at 10 years Effet: Iron deficiency: LSG 14% vs LRYGB 41% p=0.017 (iron deficiency)

Population: Severely obese adults undergoing bariatric surgery

Review

Male and female pattern hair loss.

Dose: None vs: Placebo Effet: None None

Key Statistics

Études

6441

Participants

↑

Positive

Note

Referenced Papers

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial. Other

Clinical and experimental … 2026

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. Review

American journal of … 2026

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of the SLEEVEPASS randomized clinical trial. RCT

The British journal … 2025 10 citations

Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. Other

Journal of the … 2025 3 citations

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot … Other

International journal of … 2025 3 citations

Male and female pattern hair loss. Review

Australian prescriber 2025 2 citations

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. Other

Dermatology practical & … 2025 1 citations

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: … Other

International journal of … 2025

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs. Other

Frontiers in veterinary … 2024 15 citations

The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral … RCT

Journal of cosmetic … 2024 14 citations

Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. Review

Journal of clinical … 2024 11 citations

Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. Other

The Australasian journal … 2024 5 citations

Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. Other

Archives of dermatological … 2024 4 citations

Inter-strain variability in responses to a single administration of the cannabidiol-rich cannabis extract in mice. Other

Food and chemical … 2024 1 citations

Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective … Other

JAAD international 2024 1 citations

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Review

Cureus 2023 13 citations

Combination therapy in female pattern hair loss. Review

Journal of cosmetic … 2023 3 citations

Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension … Other

Journal of personalized … 2022 16 citations

Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: … Case Report

Frontiers in medicine 2022 14 citations

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative … Other

PEC innovation 2022 11 citations

Spironolactone for treatment of female pattern hair loss. Other

Journal of the … 2020 43 citations

Spironolactone in dermatology: uses in acne and beyond. Review

Clinical and experimental … 2020 20 citations

Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind … Other

Dermatology practical & … 2020 10 citations

Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Meta-Analysis

The Journal of … 2019 101 citations

Androgens in women: Androgen-mediated skin disease and patient evaluation. Review

Journal of the … 2019 95 citations

Androgens in women: Hormone-modulating therapies for skin disease. Review

Journal of the … 2019 55 citations

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Review

Breast cancer research … 2019 36 citations

Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. Other

Polski merkuriusz lekarski … 2019 4 citations

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Observational

International journal of … 2018 142 citations

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Review

International journal of … 2018 129 citations

Female pattern hair loss. Other

Australian journal of … 2018 8 citations

Interventions for female pattern hair loss. Meta-Analysis

The Cochrane database … 2016 18 citations

Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. Review

The Medical clinics … 2015 66 citations

Evidence-based approach to cutaneous hyperandrogenism in women. Review

Journal of the … 2015 50 citations

Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. Other

Journal of the … 2015 43 citations

Hair loss in women. Review

Clinical obstetrics and … 2015 9 citations

Female pattern hair loss. Review

Current problems in … 2015 8 citations

[Spironolactone in dermatological treatment. On and off label indications]. Other

Der Hautarzt; Zeitschrift … 2013 19 citations

Female pattern alopecia: current perspectives. Review

International journal of … 2013

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Review

The British journal … 2011 96 citations

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. Case Report

The Australasian journal … 2011 44 citations

Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Other

Dermatologic clinics 2010 80 citations

Use of spironolactone in dermatology. Review

Skinmed 2010 33 citations

Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl. Case Report

The Australasian journal … 2009 31 citations

Hair loss in women. Review

Seminars in cutaneous … 2009 4 citations

Treating female pattern hair loss. Noticeable hair loss can be deeply distressing. Here are some medical treatments that may help. Other

Harvard women's health … 2009

A review of hormonal therapy for female pattern (androgenic) alopecia. Review

Dermatology online journal 2008

Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. Case Report

The Australasian journal … 2007 32 citations

[The treatment of female pattern hair loss]. Review

Duodecim; laaketieteellinen aikakauskirja 2006

Evaluation and treatment of male and female pattern hair loss. Other

Journal of the … 2005 247 citations

Treatment of female pattern hair loss with oral antiandrogens. Other

The British journal … 2005 205 citations

Chronic telogen effluvium: a study of 5 patients over 7 years. Case Report

Journal of the … 2005 64 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

hairloss:: 100-200 mg/day (prescription)

Limite supérieure : 200 mg/day (hair loss indication)

Posologies étudiées dans la recherche

Posologie	Durée	Effet	N
None	--	Neutral	--
Bicalutamide 50 mg/day; spironolactone 100 mg/day	24 weeks	Positive	204
Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily	24 weeks	Positive	80
Spironolactone 100 mg once daily	24 weeks	Positive	48
None	520 weeks	Positive	240
None	--	Positive	--
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi	16 weeks	Positive	45
4 g	--	Neutral	--

Moment optimal de prise : Once or twice daily with food; prescription required

Safety & Side Effects

Effets indésirables signalés

⚠ Menstrual irregularities
⚠ Breast tenderness
⚠ Hyperkalemia (elevated potassium levels)
⚠ Dizziness and orthostatic hypotension
⚠ Frequent urination

Interactions connues

● ACE inhibitors and ARBs (increased hyperkalemia risk)
● Potassium supplements and potassium-sparing diuretics (dangerous hyperkalemia)
● NSAIDs (may reduce diuretic effectiveness and increase kidney risk)
● Digoxin (spironolactone may increase digoxin levels)

Apport maximal tolérable : 200 mg/day (hair loss indication)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Spironolactone help with Perte Capillaire Féminine?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that Spironolactone may support Perte Capillaire Féminine management. Our evidence grade is A (Strong Evidence).

How much Spironolactone should I take for Perte Capillaire Féminine?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Spironolactone?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Spironolactone and Perte Capillaire Féminine?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

Related Evidence

Autres ingrédients pour Perte Capillaire Féminine

Minoxidil A Vitamine D A Thérapie laser de faible intensité A Nutrafol A Saw Palmetto B

Spironolactone pour d'autres pathologies

Alopécie Androgénétique A

Verdict rapide

Basé sur 19 études (2 meta-analyses, 4 RCTs) avec 5,743 participants au total. 16/19 études montrent des effets positifs.

Evidence Strength92%

High confidence

Synthèse des études

RCT (2)Meta (2)Other (41)

Comparer les alternatives

Découvrez comment d'autres ingrédients se comparent pour cette condition.Découvrez comment d'autres ingrédients se comparent pour cette pathologie.

Voir tous les ingrédients pour Perte Capillaire Féminine

En savoir plus

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.